|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
35,410,000 |
Market
Cap: |
14.28(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$180.52 - $413.31 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 463 |
Guru Rank Value : 3 |
Guru Occurances : 1 |
|
|
|
|
|
|
|
Company Profile Medpace Holdings is a holding company. Through its subsidiaries, Co. is a clinical contract research organization focused on providing scientifically-driven outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Co. provides a suite of services supporting the clinical development process from Phase I to Phase IV across a range of therapeutic areas. Co.'s services include medical department, clinical trial management, study start-up, patient recruitment and retention, clinical monitoring, risk-based monitoring, regulatory affairs, medical writing, biometrics and data sciences, pharmacovigilance, and quality assurance.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
2,000,000 |
Total Buy Value |
$0 |
$0 |
$0 |
$309,116,534 |
Total People Bought |
0 |
0 |
0 |
2 |
Total Buy Transactions |
0 |
0 |
0 |
34 |
Total Shares Sold |
1,742,072 |
2,404,472 |
3,583,248 |
3,608,378 |
Total Sell Value |
$699,894,249 |
$883,563,199 |
$1,169,841,547 |
$1,175,475,107 |
Total People Sold |
6 |
6 |
8 |
8 |
Total Sell Transactions |
39 |
65 |
84 |
89 |
End Date |
2023-12-28 |
2023-09-26 |
2023-03-28 |
2022-03-28 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Burwig Susan E |
Exec. VP, Operations |
|
2024-03-15 |
4 |
S |
$403.00 |
$41,106 |
D/D |
(102) |
15,181 |
|
-2% |
|
Keating Ashley M. |
Director |
|
2024-03-14 |
4 |
S |
$409.87 |
$102,468 |
D/D |
(250) |
250 |
|
0% |
|
Keating Ashley M. |
Director |
|
2024-03-14 |
4 |
OE |
$84.36 |
$42,180 |
D/D |
500 |
500 |
|
- |
|
Medpace Investors, Llc |
10% Owner |
|
2024-03-08 |
4 |
S |
$408.71 |
$10,217,750 |
D/D |
(25,000) |
4,733,019 |
|
1% |
|
Troendle August J. |
CEO |
|
2024-03-08 |
4 |
S |
$408.71 |
$10,217,750 |
I/I |
(25,000) |
4,733,019 |
|
1% |
|
Medpace Investors, Llc |
10% Owner |
|
2024-03-07 |
4 |
S |
$410.74 |
$30,805,500 |
D/D |
(75,000) |
4,758,019 |
|
2% |
|
Troendle August J. |
CEO |
|
2024-03-07 |
4 |
S |
$410.74 |
$30,805,500 |
I/I |
(75,000) |
4,758,019 |
|
2% |
|
Keating Ashley M. |
Director |
|
2024-03-07 |
4 |
S |
$415.00 |
$195,880 |
D/D |
(472) |
0 |
|
2% |
|
Keating Ashley M. |
Director |
|
2024-03-07 |
4 |
OE |
$54.99 |
$25,955 |
D/D |
472 |
472 |
|
- |
|
Medpace Investors, Llc |
10% Owner |
|
2024-03-06 |
4 |
S |
$412.98 |
$41,298,000 |
D/D |
(100,000) |
4,833,019 |
|
2% |
|
Troendle August J. |
CEO |
|
2024-03-06 |
4 |
S |
$412.98 |
$41,298,000 |
I/I |
(100,000) |
4,833,019 |
|
2% |
|
Geiger Jesse J |
President |
|
2024-03-05 |
4 |
OE |
$90.65 |
$1,602,601 |
D/D |
17,679 |
21,503 |
|
- |
|
Troendle August J. |
CEO |
|
2024-03-05 |
4 |
S |
$402.70 |
$20,135,000 |
I/I |
(50,000) |
4,933,019 |
|
0% |
|
Medpace Investors, Llc |
10% Owner |
|
2024-03-05 |
4 |
S |
$402.70 |
$20,135,000 |
D/D |
(50,000) |
4,933,019 |
|
0% |
|
Geiger Jesse J |
President |
|
2024-03-04 |
4 |
S |
$403.03 |
$8,996,033 |
D/D |
(22,321) |
3,824 |
|
-0% |
|
Geiger Jesse J |
President |
|
2024-03-04 |
4 |
OE |
$90.65 |
$2,023,399 |
D/D |
22,321 |
26,145 |
|
- |
|
Troendle August J. |
CEO |
|
2024-03-04 |
4 |
S |
$403.12 |
$20,156,000 |
I/I |
(50,000) |
4,983,019 |
|
-0% |
|
Medpace Investors, Llc |
10% Owner |
|
2024-03-04 |
4 |
S |
$403.12 |
$20,156,000 |
D/D |
(50,000) |
4,983,019 |
|
-0% |
|
Medpace Investors, Llc |
10% Owner |
|
2024-03-01 |
4 |
S |
$401.88 |
$32,150,400 |
D/D |
(80,000) |
5,033,019 |
|
0% |
|
Troendle August J. |
CEO |
|
2024-03-01 |
4 |
S |
$401.88 |
$32,150,400 |
I/I |
(80,000) |
5,033,019 |
|
0% |
|
Ewald Stephen P |
General Counsel & Corp. Secy. |
|
2024-03-01 |
4 |
S |
$400.79 |
$140,277 |
D/D |
(350) |
13,341 |
|
0% |
|
Medpace Investors, Llc |
10% Owner |
|
2024-02-29 |
4 |
S |
$393.71 |
$7,874,200 |
D/D |
(20,000) |
5,113,019 |
|
-1% |
|
Troendle August J. |
CEO |
|
2024-02-29 |
4 |
S |
$393.71 |
$7,874,200 |
I/I |
(20,000) |
5,113,019 |
|
-1% |
|
Geiger Jesse J |
President |
|
2024-02-29 |
4 |
S |
$393.51 |
$1,006,586 |
D/D |
(2,558) |
3,824 |
|
-1% |
|
Ewald Stephen P |
General Counsel & Corp. Secy. |
|
2024-02-29 |
4 |
S |
$393.51 |
$457,646 |
D/D |
(1,163) |
13,691 |
|
-1% |
|
533 Records found
|
|
Page 1 of 22 |
|
|